As you probably know, there’s a lot of Niacin in Western diets. So, when a new, potentially concerning Niacin study was published last week, the media sounded the alarm, and word spread quickly. Furthermore, those taking NAD+ boosters Nicotinamide Riboside “NR” (FAQs) (Anecdotes) and/or Nicotinamide Mononucleotide “NMN” (FAQs and Anecdotes) began to wonder whether they, too, were at risk. But, as it turns out, there are some serious flaws in this whole narrative.
Month: February 2024
We’ve written a lot about ongoing clinical trials testing NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) for Parkinson’s patients. Fortunately, Chromadex (NR sellers) CEO Rob Fried gave the following update on those trials at an investor conference earlier this week:
A common question consumers have is how much Nicotinamide Riboside “NR” (FAQs) (Anecdotes) to take daily. During an appearance on “The Story of a Brand” podcast, Chromadex (sellers of NR) CEO Rob Fried offered the following:
While obvious to some, many consumers often wonder whether the supplement they’re taking is positively impacting them. If the latter is you, you might find the following useful. During an appearance on “The Story of a Brand” podcast, Chromadex (sellers of NR) CEO Rob Fried had some advice for those taking vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes) and wondering if it’s working:
During his appearance on this week’s “The Story of a Brand” podcast, Chromadex (sellers of NR) CEO Rob Fried described his own experience taking NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes). Here’s what he said (podcast and transcript below):